Divalproex Extended Release and Panitumumab Intravenous
Determining the interaction of Divalproex Extended Release and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Extended Release-Panixine
- Divalproex Extended Release-Panixine DisperDose
- Divalproex Extended Release-Panlor
- Divalproex Extended Release-Panlor Tablet
- Divalproex Extended Release-Panlor Tablets
- Divalproex Extended Release-Panlor-DC
- Panitumumab Intravenous-Divalproex Long-Acting Tablets
- Panitumumab Intravenous-Divalproex sodium
- Panitumumab Intravenous-Divalproex Sprinkle
- Panitumumab Intravenous-Divalproex Sprinkle Capsules
- Panitumumab Intravenous-Divigel
- Panitumumab Intravenous-Divigel 0.75 mg/packet for use on skin